HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transcatheter treatment of SVC syndrome from histoplasmosis-related mediastinal fibrosis in a 9-year old male.

Abstract
We report a case of mediastinal fibrosis secondary to histoplasmosis in a 9-year old male, who presented with superior vena cava syndrome. He was successfully treated by percutaneous superior vena cava stent placement in the outpatient cardiac catheterization laboratory.
AuthorsMichael Johansen, Mark Hoyer, Martin Kleiman
JournalCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (Catheter Cardiovasc Interv) Vol. 82 Issue 5 Pg. E708-11 (Nov 01 2013) ISSN: 1522-726X [Electronic] United States
PMID23436729 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2013 Wiley Periodicals, Inc.
Topics
  • Angioplasty, Balloon (instrumentation)
  • Catheterization, Central Venous (instrumentation)
  • Child
  • Histoplasmosis (complications, diagnosis, immunology, microbiology)
  • Humans
  • Immunocompromised Host
  • Male
  • Mediastinitis (diagnosis, etiology)
  • Phlebography (methods)
  • Risk Factors
  • Sclerosis (diagnosis, etiology)
  • Stents
  • Superior Vena Cava Syndrome (diagnosis, etiology, therapy)
  • T-Lymphocytes (immunology, microbiology)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: